Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized Haplo-Cord transplantation study in pediatric hematopoietic stem cell transplantation
ChiCTR2000029458Phase 2Recruiting
- Sponsor
- Shanghai Children's Hospital
- Start
- Mar 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Hematopoietic Stem Cell Transplantation (Medical College of Wisconsin) and hematopoietic progenitor cells, cord blood in stem cell transplant (SCT), sponsored by Shanghai Children's Hospital. Primary endpoints: Hematopoietic reconstitution, Immune reconstruction and 4 more. Started Mar 2020; status: recruiting.
02
Drugs
Hematopoietic Stem Cell Transplantation (Medical College of Wisconsin)hematopoietic progenitor cells, cord blood
03
Conditions
stem cell transplant (SCT)
Beyond the preview
Go deeper on ChiCTR2000029458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029458.